CryoCell International Valuation
| CCEL Stock | USD 3.43 0.06 1.78% |
At this time, the firm appears to be undervalued. CryoCell International shows a prevailing Real Value of $4.61 per share. The current price of the firm is $3.43. Our model approximates the value of CryoCell International from analyzing the firm fundamentals such as Profit Margin of (0.01) %, current valuation of 36.98 M, and Return On Equity of 1.29 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting CryoCell International's valuation include:
Price Book 9.7236 | Enterprise Value | Enterprise Value Ebitda 7.1676 | Price Sales 0.8695 | Enterprise Value Revenue 1.1649 |
Undervalued
Today
Please note that CryoCell International's price fluctuation is moderately volatile at this time. Calculation of the real value of CryoCell International is based on 3 months time horizon. Increasing CryoCell International's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the CryoCell stock is determined by what a typical buyer is willing to pay for full or partial control of CryoCell International. Since CryoCell International is currently traded on the exchange, buyers and sellers on that exchange determine the market value of CryoCell Stock. However, CryoCell International's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.43 | Real 4.61 | Target 8.5 | Hype 3.41 |
The intrinsic value of CryoCell International's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence CryoCell International's stock price.
Estimating the potential upside or downside of CryoCell International helps investors to forecast how CryoCell stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of CryoCell International more accurately as focusing exclusively on CryoCell International's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use CryoCell International's intrinsic value based on its ongoing forecasts of CryoCell International's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against CryoCell International's closest peers.
CryoCell International Cash |
|
CryoCell Revenue by Product
CryoCell International Total Value Analysis
CryoCell International is currently forecasted to have valuation of 36.98 M with market capitalization of 27.61 M, debt of 12.93 M, and cash on hands of 2.96 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the CryoCell International fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
36.98 M | 27.61 M | 12.93 M | 2.96 M |
CryoCell International Investor Information
About 42.0% of the company shares are held by company insiders. The company recorded a loss per share of 0.06. CryoCell International last dividend was issued on the 21st of May 2025. CryoCell International is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 7.3 M | 6.9 M |
|
|
CryoCell International Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. CryoCell International has an asset utilization ratio of 49.45 percent. This suggests that the Company is making $0.49 for each dollar of assets. An increasing asset utilization means that CryoCell International is more efficient with each dollar of assets it utilizes for everyday operations.CryoCell International Profitability Analysis
Taking into consideration CryoCell International's profitability measurements, CryoCell International is yielding more profit at this time then in previous quarter. It has a moderate probability of reporting better profitability numbers in March. Profitability indicators assess CryoCell International's ability to earn profits and add value for shareholders.Net Income | First Reported 1996-02-29 | Previous Quarter 355.8 K | Current Value 1.6 M | Quarterly Volatility 1.6 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.56 | 0.68 |
|
|
For CryoCell International profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CryoCell International to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CryoCell International utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CryoCell International's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CryoCell International over time as well as its relative position and ranking within its peers.
CryoCell International Earnings per Share Projection vs Actual
The next projected EPS of CryoCell International is estimated to be -0.105 with future projections ranging from a low of -0.105 to a high of -0.105. CryoCell International's most recent 12-month trailing earnings per share (EPS TTM) is at -0.06. Please be aware that the consensus of earnings estimates for CryoCell International is based on EPS before non-recurring items and includes expenses related to employee stock options.CryoCell International Earnings Estimation Breakdown
The calculation of CryoCell International's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of CryoCell International is estimated to be -0.105 with the future projection ranging from a low of -0.105 to a high of -0.105. Please be aware that this consensus of annual earnings estimates for CryoCell International is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.1 Lowest | Expected EPS | -0.1 Highest |
CryoCell International Earnings Projection Consensus
Suppose the current estimates of CryoCell International's value are higher than the current market price of the CryoCell International stock. In this case, investors may conclude that CryoCell International is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and CryoCell International's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 30th of November 2026 | Current EPS (TTM) | |
| 1 | 7.76% | 0.0 | -0.105 | -0.06 |
CryoCell International Ownership Allocation
The market capitalization of CryoCell International is $27.61 Million. CryoCell International retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the firm is less than the current market value, you may not be able generate positive returns on investment in the long run.CryoCell International Profitability Analysis
The company reported the previous year's revenue of 31.99 M. Net Income was 402.1 K with profit before overhead, payroll, taxes, and interest of 24.47 M.CryoCell International Past Distributions to stockholders
About CryoCell International Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of CryoCell International. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of CryoCell International based exclusively on its fundamental and basic technical indicators. By analyzing CryoCell International's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of CryoCell International's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of CryoCell International. We calculate exposure to CryoCell International's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of CryoCell International's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 27.6 M | 29 M | |
| Pretax Profit Margin | 0.08 | 0.08 | |
| Operating Profit Margin | 0.10 | 0.10 | |
| Net Profit Margin | 0.01 | 0.01 | |
| Gross Profit Margin | 0.68 | 0.56 |
A single share of CryoCell International represents a small ownership stake in the entity. As a stockholder of CryoCell, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
CryoCell International Dividends Analysis For Valuation
Please note that CryoCell International has scaled down on payment of dividends at this time. At this time, CryoCell International's Earnings Yield is quite stable compared to the past year. Price Earnings Ratio is expected to rise to 165.67 this year, although the value of Retained Earnings will most likely fall to (31 M).
There are various types of dividends CryoCell International can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of CryoCell shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from CryoCell International directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When CryoCell pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of CryoCell International by the value of the dividends paid out.
CryoCell International Growth Indicators
Investing in growth stocks can be very risky. If the company such as CryoCell International does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 8.2 M | |
| Quarterly Earnings Growth Y O Y | -0.308 |
CryoCell International Current Valuation Indicators
CryoCell International's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final CryoCell International's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as CryoCell International, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use CryoCell International's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes CryoCell International's worth.When determining whether CryoCell International is a strong investment it is important to analyze CryoCell International's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CryoCell International's future performance. For an informed investment choice regarding CryoCell Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in CryoCell International. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in discontinued. For more information on how to buy CryoCell Stock please use our How to buy in CryoCell Stock guide.You can also try the Sync Your Broker module to sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors..
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CryoCell International. Projected growth potential of CryoCell fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive CryoCell International assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Quarterly Earnings Growth (0.31) | Dividend Share 0.65 | Earnings Share (0.06) | Revenue Per Share | Quarterly Revenue Growth (0.03) |
Investors evaluate CryoCell International using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating CryoCell International's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. External factors like market trends, sector rotation, and investor psychology can cause CryoCell International's market price to deviate significantly from intrinsic value.
It's important to distinguish between CryoCell International's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding CryoCell International should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, CryoCell International's market price signifies the transaction level at which participants voluntarily complete trades.